Lonza today announced that it has received all regulatory approvals for the proposed acquisition of Capsugel S.A. With all final regulatory approvals in place, Lonza can now complete the transaction, which is expected to close in the next days subject to the satisfaction of customary closing conditions.   According to Lonza, following the closing of the Capsugel acquisition, Lonza will further strengthen its position as one of the world’s leading and most-trusted suppliers to the pharmaceuti...